These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15297310)

  • 1. Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.
    Chatterjee M; Stühmer T; Herrmann P; Bommert K; Dörken B; Bargou RC
    Blood; 2004 Dec; 104(12):3712-21. PubMed ID: 15297310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
    Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
    Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
    Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
    J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3.
    Takizawa T; Yanagisawa M; Ochiai W; Yasukawa K; Ishiguro T; Nakashima K; Taga T
    Cytokine; 2001 Mar; 13(5):272-9. PubMed ID: 11243705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells.
    Hönemann D; Chatterjee M; Savino R; Bommert K; Burger R; Gramatzki M; Dörken B; Bargou RC
    Int J Cancer; 2001 Sep; 93(5):674-80. PubMed ID: 11477577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells.
    Xie Z; Tang S; Ye G; Wang P; Li J; Liu W; Li M; Wang S; Wu X; Cen S; Zheng G; Ma M; Wu Y; Shen H
    Stem Cell Res Ther; 2018 Jan; 9(1):13. PubMed ID: 29357923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells.
    Gao L; Zhang C; Zhang X; Gao L; Hao L; Chen XH
    Hematology; 2014 Apr; 19(3):148-57. PubMed ID: 23896383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
    Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.
    Tai YT; Fulciniti M; Hideshima T; Song W; Leiba M; Li XF; Rumizen M; Burger P; Morrison A; Podar K; Chauhan D; Tassone P; Richardson P; Munshi NC; Ghobrial IM; Anderson KC
    Blood; 2007 Sep; 110(5):1656-63. PubMed ID: 17510321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1.
    Tian ZJ; Cui W; Li YJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Chen L; An W
    Acta Pharmacol Sin; 2004 Sep; 25(9):1157-64. PubMed ID: 15339391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.
    Horiguchi A; Oya M; Marumo K; Murai M
    Kidney Int; 2002 Mar; 61(3):926-38. PubMed ID: 11849447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
    Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
    Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
    Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
    J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival.
    Chatterjee M; Jain S; Stühmer T; Andrulis M; Ungethüm U; Kuban RJ; Lorentz H; Bommert K; Topp M; Krämer D; Müller-Hermelink HK; Einsele H; Greiner A; Bargou RC
    Blood; 2007 Jan; 109(2):720-8. PubMed ID: 17003370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream effectors of oncogenic ras in multiple myeloma cells.
    Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
    Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma.
    Raje N; Kumar S; Hideshima T; Roccaro A; Ishitsuka K; Yasui H; Shiraishi N; Chauhan D; Munshi NC; Green SR; Anderson KC
    Blood; 2005 Aug; 106(3):1042-7. PubMed ID: 15827128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
    Hashizume M; Hayakawa N; Mihara M
    Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.